Posters

Poster Title: Immunomic Therapeutics Announces Presentation on Self-amplifying RNA vaccines using the UNITE® platform for Triple-negative Breast Cancer at SITC 39th Annual Meeting 2024 Presentation Date: Friday, November 8, 2024

Poster Title: Harnessing soluble CD40L to enhance anti-tumor efficacy of Her2-LAMP DNA vaccine using UNITE™ platform Presentation Date: Tuesday April 12, 2022, 1:30 PM - 5:00 PM ET Download poster here.

Poster Title: LAMP1 targeting of the large T antigen of Merkel cell polyomavirus elicits potent CD4+ T cell responses, tumor inhibition, and provides rationale for first-in-human trial Presentation Date: Monday April

Click below to view ITI's abstract, titled, "Development and Characterization of a HCMV multiantigen therapeutic vaccine for GBM using the UNITE platform, published by ASCO, May 18, 2021: Meeting Library

Poster Title: LAMP1 targeting of the large T antigen of Merkel cell polyomavirus elicits potent CD4+ T cell responses and prevents tumor growth Presentation Date: 11/11/2020 - 11/14/2020, 9:00 am

Poster Title: Glypican-3-LAMP: A novel DNA vaccine for liver cancer immunotherapy Presentation Date: August 17-18, 2020 3:30-5PM EST Download poster here.

Poster Title: Lysosomal-associated membrane protein-1-targeting of Epstein–Barr virus nuclear antigen 1 (EBNA1) elicits potent immune responses and inhibits tumor growth in preclinical studies by Dr. Pratima Sinha, Ph.D. Presentation Date:

Poster Title: Lysosomal-associated membrane protein-1-targeting of a poly-neoepitope DNA vaccine elicits potent immune responses and inhibits tumor growth by Dr. Pratima Sinha, Ph.D. Presentation Date: Saturday, November 9th 7:00 am

Poster Title: Functional evaluation of isoforms present in pDNA vaccines Poster Session Date: Tuesday, November 6, 2018 Location: Aldevron, Fargo ND   Download poster here.

Poster Title: Lysosomal-associated membrane protein-1-targeting of the large T antigen of Merkel cell polyomavirus elicits potent CD4+ T cell responses Poster Session Date and Time: Monday, October 21, 2019 11:15

Poster Title: DNA vaccine co-expressing Her2/ErbB2 antigen, fused with LAMP, elicits strong antitumor effects in vivo by increasing tumor infiltration with CD8+ T cells Session Category: Immunology Session Title: Late-Breaking